Ignite Creation Date:
2025-12-24 @ 1:30 PM
Ignite Modification Date:
2026-01-01 @ 7:56 AM
Study NCT ID:
NCT02388295
Status:
COMPLETED
Last Update Posted:
2017-09-25
First Post:
2015-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09-19
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-09
First Submit QC Date:
None
Study First Post Date:
2015-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-23
Results First Submit QC Date:
None
Results First Post Date:
2017-09-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-18
Last Update Post Date:
2017-09-25
Last Update Post Date Type:
ACTUAL